The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years.The drug, sold under the brand ...

She had been in pain for the entire 90-minute flight. Her abdomen was so distended and tender that she felt as if it might ...

Pediatricians at Penn State Health Children’s Hospital are seeing cases of the flu, RSV and other viral respiratory ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...